The health needs of people leaving prison with a history of methamphetamine and/or opioid use

被引:3
作者
Cumming, Craig [1 ,8 ]
Kinner, Stuart A. [2 ,3 ,4 ,5 ]
McKetin, Rebecca [6 ]
Li, Ian [7 ]
Preen, David B. [1 ]
机构
[1] Univ Western Australia, Ctr Hlth Serv Res, Sch Populat & Global Hlth, Perth, Australia
[2] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Australia
[3] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Australia
[4] Griffith Univ, Griffith Criminol Inst, Brisbane, Australia
[5] Curtin Univ, Sch Populat Hlth, Perth, Australia
[6] UNSW Sydney, Natl Drug & Alcohol Res Ctr, Sydney, Australia
[7] Univ Western Australia, Sch Populat & Global Hlth, Perth, Australia
[8] Univ Western Australia, Ctr Hlth Serv Res, Sch Populat & Global Hlth, M431,35 Stirling Highway, Crawley, WA 6009, Australia
基金
英国医学研究理事会;
关键词
harm reduction; methamphetamine; opioid; prisons; substance-related disorders; INJECT DRUGS; PREDICTORS; OVERDOSE; RELEASE; RISK; HIV;
D O I
10.1111/dar.13636
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
IntroductionMethamphetamine use is more common than opioid use among prison entrants in some countries, including Australia, yet most research and policy focuses on opioid use. This suggests that traditional opioid-focused interventions are no longer appropriate for the majority of this group in countries such as Australia. To inform policy and practice, we compared socio-demographic characteristics and health needs of people leaving prison with a history of methamphetamine use and/or opioid use. MethodsA cross-sectional survey of incarcerated adults administered the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test was used to identify moderate-/high-risk methamphetamine use (n = 909), opioid use (n = 115) or combined methamphetamine/opioid use (n = 356) before incarceration. We compared groups using modified log-linked Poisson regression with robust error variance. ResultsCompared to the opioid-only group, the methamphetamine-only group were: significantly more often aged <25 years; significantly more likely to identify as Indigenous; significantly less likely to have a history of prior incarceration, drug injection or overdose. A significantly lower proportion of methamphetamine-only and methamphetamine-and-opioid participants self-reported current hepatitis C infection compared to opioid-only participants. A majority of participants in all groups screened positive for current psychological distress according to the K10. Discussion and ConclusionsPeople leaving prison with a history of methamphetamine use differ from opioid users with respect to demographics, patterns of substance use and related health concerns. Treatment and harm reduction efforts for people who experience incarceration must respond to patterns of drug use in this population, and invest at scale in coordinated, continuous services for co-occurring substance use and mental health problems.
引用
收藏
页码:778 / 784
页数:7
相关论文
共 33 条
  • [1] Australian Bureau of Statistics, 2017, 4363 0 NAT HLTH SURV
  • [2] Australian Bureau of Statistics, 2021, PRIS AUSTR CANB
  • [3] Australian Institute of Health and Welfare, 2020, PROF IND AUSTR
  • [4] Australian Institute of Health and Welfare, 2019, 246 AIHW PHE
  • [5] Mortality After Prison Release: Opioid Overdose and Other Causes of Death, Risk Factors, and Time Trends From 1999 to 2009
    Binswanger, Ingrid A.
    Blatchford, Patrick J.
    Mueller, Shane R.
    Stern, Marc F.
    [J]. ANNALS OF INTERNAL MEDICINE, 2013, 159 (09) : 592 - 600
  • [6] Factors associated with drug use in prison - results from the Norwegian offender mental health and addiction (NorMA) study
    Bukten, Anne
    Lund, Ingunn Olea
    Kinner, Stuart A.
    Rognli, Eline Borger
    Havnes, Ingrid Amalia
    Muller, Ashley Elizabeth
    Stavseth, Marianne Riksheim
    [J]. HEALTH & JUSTICE, 2020, 8 (01)
  • [7] Prevalence of Mental Health Needs, Substance Use, and Co-occurring Disorders Among People Admitted to Prison
    Butler, Amanda
    Nicholls, Tonia
    Samji, Hasina
    Fabian, Sheri
    Lavergne, M. Ruth
    [J]. PSYCHIATRIC SERVICES, 2022, 73 (07) : 737 - 744
  • [8] A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders
    Chan, Brian
    Freeman, Michele
    Ayers, Chelsea
    Korthuis, P. Todd
    Paynter, Robin
    Kondo, Karli
    Kansagara, Devan
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2020, 216
  • [9] Increased Drug Use and STI Risk with Injection Drug Use Among HIV-Seronegative Heterosexual Methamphetamine Users
    Cheng, W. Susan
    Garfein, Richard S.
    Semple, Shirley J.
    Strathdee, Steffanie A.
    Zians, James K.
    Patterson, Thomas L.
    [J]. JOURNAL OF PSYCHOACTIVE DRUGS, 2010, 42 (01) : 11 - 18
  • [10] Self-report among injecting drug users: a review
    Darke, S
    [J]. DRUG AND ALCOHOL DEPENDENCE, 1998, 51 (03) : 253 - 263